Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study
Author:
Affiliation:
1. Section of Dermatology – Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy
Publisher
Hindawi Limited
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15524
Reference37 articles.
1. State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis
2. Psoriasis and comorbid diseases
3. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders
4. Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
5. Real‐world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA ( EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real‐life clinical practice) study
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience;Clinical, Cosmetic and Investigational Dermatology;2023-12
2. Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics;Pediatric Health, Medicine and Therapeutics;2023-11
3. Nail psoriasis and nail lichen planus: Updates on diagnosis and management;Journal of the American Academy of Dermatology;2023-11
4. Development of a Deep Eutectic Solvent-Assisted Kaempferol Hydrogel: A Promising Therapeutic Approach for Psoriasis-like Skin Inflammation;Molecular Pharmaceutics;2023-10-31
5. Real‐world data show high efficacy of IL23 inhibitors guselkumab and risankizumab in psoriatic arthritis and difficult‐to‐treat areas;International Journal of Dermatology;2023-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3